MAPT and Alzheimer disease: Transgenic AD mice treated with vitamin A intraperitoneally for 8 weeks showed decreased cerebral tau phosphorylation and Aβ deposition, decreased microglia and astrocyte activation, attenuated neurodegeneration and improved spatial memory and learning [293].